Acute Erythroleukemia

Search Trials
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Feb 25, 2021
First Changed:
Mar 12, 2014
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
clofarabinedaunorubicin hydrochlorideclinical observationcytarabinedecitabinelaboratory biomarker analysisquality-of-life assessmentquestionnaire administration
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Status:
Active, not recruiting
Last Changed:
Dec 1, 2021
First Changed:
Feb 26, 2014
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
eltrombopag olamine
Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
Status:
Active, not recruiting
Last Changed:
Jun 30, 2022
First Changed:
Jan 9, 2008
Disease(s):
Adult Acute Megakaryoblastic Leukemia
Intervention(s):
CarboplatinLaboratory Biomarker AnalysisTopotecan HydrochlorideVeliparib
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Jun 29, 2022
First Changed:
Jul 23, 2010
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Allogeneic Hematopoietic Stem Cell TransplantationAnti-Thymocyte GlobulinAzacitidineBusulfanFludarabine PhosphateLaboratory Biomarker AnalysisMethotrexatePharmacological StudyTacrolimus
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Jun 29, 2022
First Changed:
Apr 15, 2008
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AzacitidineGemtuzumab Ozogamicin

Connect. Empower. Inspire.